Kathleen Beusterien

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Peritoneal Dialysis

Replacement Therapy

Decision Making

Prognostic Factors

Top Venues

Future oncology (London, England)

Patient preference and adherence

Orphanet journal of rare diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Kathleen Beusterien, Oliver Will, Emuella Flood, Susan McCutcheon, deMauri S Mackie, Stella Mokiou
A Novel Approach to Computing Preference Estimates for Different Treatment Pathways: An Application in Oncology. The patient 17 (4) (2024)
Kathleen Beusterien, Oliver Will, Emuella Flood, Susan McCutcheon, deMauri S Mackie, Stella Mokiou
A Novel Approach to Computing Preference Estimates for Different Treatment Pathways: An Application in Oncology. The patient (2024)
Kathleen Beusterien, Oliver Will, Emuella Flood, Susan McCutcheon, deMauri S Mackie, Stella Mokiou
A Novel Approach to Computing Preference Estimates for Different Treatment Pathways: An Application in Oncology. The patient 17 (4) (2024)
Kathleen Beusterien, Oliver Will, Emuella Flood, Susan McCutcheon, deMauri S Mackie, Stella Mokiou
A Novel Approach to Computing Preference Estimates for Different Treatment Pathways: An Application in Oncology. The patient 17 (4) (2024)
Tanya Collin-Histed, Madeline Stoodley, Kathleen Beusterien, Deborah Elstein, Dena H Jaffe, Shoshana Revel-Vilk, Elin Haf Davies, null null
A global neuronopathic gaucher disease registry (GARDIAN): a patient-led initiative. Orphanet journal of rare diseases 18 (1) (2023)
Suvina Amin, Sara M Tolaney, M Janelle Cambron-Mellott, Kathleen Beusterien, Martine C Maculaitis, Emily Mulvihill, Reshma Shinde, Kimmie McLaurin
Benefit-risk trade-offs in treatment choice in advanced HER2 negative breast cancer: patient and oncologist perspectives. Future oncology (London, England) 18 (16) (2022)
Jinender Kumar, M Janelle Cambron-Mellott, Tom Tencer, Oliver Will, deMauri S Mackie, Kathleen Beusterien
Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment. Patient preference and adherence 15 (2021)
M Janelle Cambron-Mellott, Jaromir Mikl, Joana E Matos, Jennifer G Erensen, Kathleen Beusterien, Marc J Cataldo, Bernadette Hallissey, Gregory W Mattingly
Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment. Patient preference and adherence 15 (2021)
Tom Tencer, Oliver Will, Jinender Kumar, M Janelle Cambron-Mellott, deMauri S Mackie, Kathleen Beusterien
Patient and neurologist preferences in the UK for relapsing-remitting multiple sclerosis treatments: findings from a discrete choice experiment. Current medical research and opinion 37 (9) (2021)
Rebecca L Stone, M Janelle Cambron-Mellott, Kathleen Beusterien, Martine C Maculaitis, Stephanie Ritz, Emily Mulvihill, Matthew Monberg, Elizabeth A Szamreta, Suvina Amin, Kimmie McLaurin
Patients' and oncologists' preferences for second-line maintenance PARP inhibitor therapy in epithelial ovarian cancer. Future oncology (London, England) (2021)